STAT3-overactive cancers can activate drug resistance genes like antiapoptotic BCL2, but inducing STAT3-dependent alkaliptosis may be a rational strategy to overcome this resistance (Chen et al., 2022c). This evidence concerns the gene STAT3 and cancer.